Navigation Links
Blood tests and better communication skills could cut over-prescribing of antibiotics
Date:5/21/2009

Improving communications skills and the use of a simple blood test could help cut the growing number of inappropriate prescriptions of antibiotics, a joint Cardiff University trial has discovered.

In a major new clinical trial, published in the British Medical Journal, a team of researchers from Cardiff University's School of Medicine together with researchers from the Maastricht University Medical Centre in the Netherlands found those GPs in primary care who underwent training in advanced communications skills and those who made use of a simple blood test prescribed fewer antibiotics for lower respiratory tract infections, which generally do not respond to antibiotics.

Professor Christopher Butler, Head of Department of Primary Care and Public Health at Cardiff University who led the trial, said: "As the problem of bacteria resistant to antibiotic treatment grows, researchers from around the world are seeking ways to improve the quality of antibiotic prescribing. Prescribing antibiotics only when patients will clearly benefit, reduces the pressure that drives antibiotic resistance.

"Conditions like acute bronchitis account for some 80% of all lower respiratory tract infections and despite evidence of little or no benefit from antibiotics, the majority of these patients are still prescribed antibiotics.

"We know that with the many pressures facing GPs, including worry about leaving pneumonia untreated, they often give patients "the benefit of the doubt" and prescribe antibiotics. Our clinical trial therefore sought to evaluate ways antibiotic prescribing could be reduced without adversely affecting patient recovery or satisfaction with care."

The trial evaluated an 'illness focussed' approach, where clinicians seek to better understand the patient's illness experience and communicate more effectively about management, and a 'disease focussed' approach, where clinicians focus on diagnosis, in this case, a simple point-of-care blood test.

The trial randomised 20 general practices in the Netherlands, where 40 GPs managed 431 patients with lower respiratory tract infection.

Dr Kerry Hood, Director of the South East Wales Trials Unit said, "The results showed that 54% of GPs practising according to usual care prescribed antibiotics, whereas 27% of those who had been trained in the advanced communication and 31% of the GPs who used the blood test methods did so. Only 23% of GPs who were trained in the advanced communication skills and who used the blood test prescribed antibiotics."

Professor Butler added, "This international collaboration between primary care researchers from Cardiff and Maastricht has shown that both an 'illness focussed' and a 'disease focussed' approach were effective in reducing antibiotic prescribing, but the two approaches combined give the greatest benefit. We need to both communicate better and improve diagnosis to do the best for our patients and to preserve antibiotic effectiveness for our children.

"Importantly, the results showed that prescribing fewer antibiotics did not mean that patients were unwell for longer. Patient's recovery and satisfaction with care were not compromised by GPs not prescribing their patient antibiotics."


'/>"/>

Contact: Dr. Christopher C. Butler
ButlerCC@cardiff.ac.uk
44-292-068-7168
Cardiff University
Source:Eurekalert

Related medicine news :

1. Cord Blood America, Inc. Announces 2009 First Quarter Results
2. Research points to a new way to protect kidneys threatened by insufficient blood or toxins
3. Cord Blood America CEO Matthew Schissler Expands on Thought Process in Owning Stem Cell Laboratory
4. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
5. Viral Infection Might Trigger High Blood Pressure
6. Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory
7. New research confirms milestone study on blood pressure meds
8. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
9. Study finds iron levels not predictive of survival for form of blood cancer
10. Genes Yield Clues to High Blood Pressure
11. Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other ... loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store ... to remind them of the lives they’ve led and the people they’ve touched. ...
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates Insurance & ... community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse in support ... abuse. To support all those victimized by the fear of violence in their own ...
(Date:2/8/2016)... ... February 08, 2016 , ... Remember the old saying “rub some dirt on ... A~, author of “Calcium Bentonite Clay” the health benefits of integrating clay into a ... the body. , A former motivational speaker, Perry A~ has since dedicated her life ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... to share this important news! AHCC and the Home Health and Hospice ICD-10 ... CMS' designee for official ICD coding guidance and clarifications, to address concerns over ...
(Date:2/8/2016)... ... ... According to research by the National Association of Dental ... certified or obtain continuing education. To increase patient awareness of the lack of ... to inform dentists and patients about the possible lack of skills and knowledge ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)...  Labvantage Lx, a newcomer to the dietary ... enhancement product, EnduramenT. Setting a new standard in ... patented biomedical breakthrough molecule that promotes the controlled ... for many biological functions including erectile function. ... the use of prescription medications, scientists working on ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. ... Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that they have ... and commercialization rights for OPA-15406 in the U.S. and ... provides manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase ... dermatitis. --> --> ...
(Date:2/8/2016)... , Feb. 8, 2016  Ventana Medical ... that hundreds of the world,s top oncologists, pathologists, ... at the 12 th annual Tucson Symposium ... evolving theories and new outcomes in cancer research ... patients, lives. Thomas Grogan , annually ...
Breaking Medicine Technology: